Related references
Note: Only part of the references are listed.Superantigen-related TH2 CD4+ T cells in nonasthmatic chronic rhinosinusitis with nasal polyps
Min-Seok Rha et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Biologic Agents for the Treatment of Chronic Rhinosinusitis With Nasal Polyps
Alison G. Kartush et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2019)
Chronic Rhinosinusitis without Nasal Polyps in Asian Patients Shows Mixed Inflammatory Patterns and Neutrophil-Related Disease Severity
Dae Woo Kim et al.
MEDIATORS OF INFLAMMATION (2019)
Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthma
Antonio Aguilar-Pimentel et al.
PLOS ONE (2017)
Endotype-driven treatment in chronic upper airway diseases
Glynnis De Greve et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2017)
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement
P. W. Hellings et al.
ALLERGY (2017)
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials
Stanley B. Cohen et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
Farhad Seif et al.
CELL COMMUNICATION AND SIGNALING (2017)
Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers
Peter Tomassen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis
Claus Bachert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Topically Administered Janus-Kinase Inhibitors Tofacitinib and Oclacitinib Display Impressive Antipruritic and Anti-Inflammatory Responses in a Model of Allergic Dermatitis
Tomoki Fukuyama et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis: A 3-year prospective observational study
Stephan Vlaminck et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2014)
Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps
Thibaut Van Zele et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2014)
Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses
Shigeru Ashino et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Inborn Errors of Human JAKs and STATs
Jean-Laurent Casanova et al.
IMMUNITY (2012)
Staphylococcus aureus enterotoxin B contributes to induction of nasal polypoid lesions in an allergic rhinosinusitis murine model
Dae Woo Kim et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2011)
Pathogenesis of chronic rhinosinusitis: Inflammation
Koen Van Crombruggen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
Kamran Ghoreschi et al.
JOURNAL OF IMMUNOLOGY (2011)
The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia
Elizabeth Kudlacz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Cytokine signaling modules in inflammatory responses
John J. O'Shea et al.
IMMUNITY (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
Share Paper
